Sphera Funds Management Ltd. Sigilon Therapeutics, Inc. Transaction History

Sphera Funds Management Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$4.42 - $10.61 $1.59 Million - $3.82 Million	-360,239 Closed	0 $0
Q2 2021 Aug 17, 2021	SELL	$9.15 - $20.17 $18,300 - $40,340	-2,000 Reduced 0.55%	360,239 $3.87 Million
Q1 2021 May 17, 2021	SELL	$18.76 - $40.91 $3.85 Million - $8.4 Million	-205,221 Reduced 36.16%	362,239 $8.07 Million
Q4 2020 Feb 16, 2021	BUY	$27.6 - $48.03 $15.7 Million - $27.3 Million	567,460 New	567,460 $26.1 Million

Ticker SGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,399,300
Description
Sigilon Therapeutics, Inc., a clinical stage biotechnology company, develops functional cures for patients with chronic diseases. Its lead product candidate is SIG-001, which is in Phase I/II clinical trial to prevent bleeding episodes in patients with moderate to severe Hemophilia A. The company is also developing SIG-005 to treat the non-neuro...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.